← SynDRA
REMDESIVIR
SynDRA canonical compound SYN0039232 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Mechanism of action | rna polymerase inhibitor |
All known targets
Mechanisms of action (all sources)
- rna polymerase inhibitor
- REP INHIBITOR
Drug classes
- Anti-Infective Agents
- Antimetabolites
- Antiviral Agents
- Noxae
- SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- veklury
- captisol-enabled remdesivir
- captisol-enabled GS 5734
- GS-5734
- Veklury
- L-Alanine, N-((S)-hydroxyphenoxyp
- RWWYLEGWBNMMLJ-YSOARWBDSA-N
- Remdesivir [USAN]
- 3QKI37EEHE
- AKOS032946252
- SB19838
- SCHEMBL17712225
- UNII-3QKI37EEHE
- GS 5734
- remdesivirum
- GS5734
- CHEBI:145994
- RefChem:6679
- GS-465124
- GS-829143
- REMDESIVIR [WHO-DD]
- DTXCID501508113
- SARS-CoV-2 antiviral agents: remdesivir
- GS 5734 [WHO-DD]
- REMDESIVIR [INN]
- MFCD31657351
- Remdesivir (GS-5734)
- C27H35N6O8P
- Veklury (TN)
- Remdesivir (Standard)
- REMDESIVIR [JAN]
- Remdesivir (JAN/USAN)
- Remdesivir(GS-5734)?
- REMDESIVIR [ORANGE BOOK]
- GTPL10715
- med.21724, Compound 178
- MSK1935
- BDBM429505
Look up REMDESIVIR in the interactive SynDRA portal →